134 related articles for article (PubMed ID: 35930777)
1. Pharmacokinetics and ex vivo pharmacodynamics of oral firocoxib administration in New Zealand White rabbits (Oryctolagus cuniculus).
Gardhouse S; Kleinhenz M; Hocker SE; Weeder M; Montgomery SR; Zhang Y; Porting A; Rooney T
Am J Vet Res; 2022 May; 83(7):. PubMed ID: 35930777
[TBL] [Abstract][Full Text] [Related]
2. Effect of flunixin meglumine and firocoxib on ex vivo cyclooxygenase activity in horses undergoing elective surgery.
Duz M; Parkin TD; Cullander RM; Marshall JF
Am J Vet Res; 2015 Mar; 76(3):208-15. PubMed ID: 25710756
[TBL] [Abstract][Full Text] [Related]
3. Examination of the pharmacokinetics and differential inhibition of cyclooxygenase isoenzymes in New Zealand white rabbits (Oryctolagus cuniculus) by the Non-Steroidal anti-inflammatory Robenacoxib.
Jeffrey A; Gardhouse S; Kleinhenz M; Hocker SE; Weeder M; Montgomery SR; Zhang Y; Porting A; Rooney T
J Vet Pharmacol Ther; 2023 Mar; 46(2):103-111. PubMed ID: 36478376
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of oral firocoxib in un-weaned calves.
Wagner SA; Fajt VR; Lo CP; Byrd CJ
J Vet Pharmacol Ther; 2021 Sep; 44(5):793-798. PubMed ID: 33817876
[TBL] [Abstract][Full Text] [Related]
5. In vitro effects and in vivo efficacy of a novel cyclooxygenase-2 inhibitor in cats with lipopolysaccharide-induced pyrexia.
McCann ME; Rickes EL; Hora DF; Cunningham PK; Zhang D; Brideau C; Black WC; Hickey GJ
Am J Vet Res; 2005 Jul; 66(7):1278-84. PubMed ID: 16111170
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of firocoxib in preweaned calves after oral and intravenous administration.
Stock ML; Gehring R; Barth LA; Wulf LW; Coetzee JF
J Vet Pharmacol Ther; 2014 Oct; 37(5):457-63. PubMed ID: 24708198
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and pharmacodynamics of three formulations of firocoxib in healthy horses.
Holland B; Fogle C; Blikslager AT; Curling A; Barlow BM; Schirmer J; Davis JL
J Vet Pharmacol Ther; 2015 Jun; 38(3):249-56. PubMed ID: 25378135
[TBL] [Abstract][Full Text] [Related]
8. SINGLE-DOSE, MULTIPLE-DOSE, AND THERAPEUTIC DRUG MONITORING PHARMACOKINETICS OF FIROCOXIB IN ASIAN ELEPHANTS (
Kottwitz J; Bechert U; Cruz-Espindola C; Christensen JM; Boothe D
J Zoo Wildl Med; 2024 Mar; 55(1):73-85. PubMed ID: 38453490
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of mavacoxib in New Zealand White rabbits (Oryctolagus cuniculus).
Wilson SE; Carpenter JW; Gardhouse S; KuKanich B
Am J Vet Res; 2023 May; 84(5):. PubMed ID: 36990439
[TBL] [Abstract][Full Text] [Related]
10. Effects of firocoxib, meloxicam, and tepoxalin administration on eicosanoid production in target tissues of healthy cats.
Goodman LA; Torres BT; Reynolds LR; Budsberg SC
Am J Vet Res; 2010 Sep; 71(9):1067-73. PubMed ID: 20807147
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of cyclo-oxygenase inhibition by two commercially available firocoxib products in horses.
Barton MH; Paske E; Norton N; King D; Giguère S; Budsberg S
Equine Vet J; 2014 Jan; 46(1):72-5. PubMed ID: 23662599
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of firocoxib after administration of multiple consecutive daily doses to horses.
Letendre LT; Tessman RK; McClure SR; Kvaternick VJ; Fischer JB; Hanson PD
Am J Vet Res; 2008 Nov; 69(11):1399-405. PubMed ID: 18980421
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and effect on renal function and average daily gain in lambs after castration and tail docking, of firocoxib and meloxicam.
Kongara K; Purchas G; Dukkipati V; Venkatachalam D; Ward N; Hunt H; Speed D
N Z Vet J; 2023 Nov; 71(6):306-314. PubMed ID: 37409352
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and metabolism of orally administered firocoxib, a novel second generation coxib, in horses.
Kvaternick V; Pollmeier M; Fischer J; Hanson PD
J Vet Pharmacol Ther; 2007 Jun; 30(3):208-17. PubMed ID: 17472652
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and bioavailability of oral firocoxib in adult, mixed-breed goats.
Stuart AK; KuKanich B; Caixeta LS; Coetzee JF; Barrell EA
J Vet Pharmacol Ther; 2019 Nov; 42(6):640-646. PubMed ID: 31435966
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and tissue concentrations of firocoxib in sows following oral administration.
Kleinhenz MD; Odland C; Williams TE; Zhang Y; Fitzgerald AH; Sidhu PK; Wulf LW; Coetzee JF
J Vet Pharmacol Ther; 2020 Sep; 43(5):491-498. PubMed ID: 32266983
[TBL] [Abstract][Full Text] [Related]
17. Measurement of Cyclooxygenase Products in Plasma as Markers for Inhibition of Cyclooxygenase Isoforms by Oral Meloxicam in New Zealand White Rabbits (
Sarvi JY; Gardhouse SM; Kleinhenz MD; Hocker SE; Weeder MM; Montgomery SR; Rooney TA
J Am Assoc Lab Anim Sci; 2023 May; 62(3):254-259. PubMed ID: 37045554
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and bioavailability of orbifloxacin oral suspension in New Zealand White rabbits (Oryctolagus cuniculus).
Watson MK; Wittenburg LA; Bui CT; Jarosz KA; Gustafson DL; Johnston MS
Am J Vet Res; 2015 Nov; 76(11):946-51. PubMed ID: 26512539
[TBL] [Abstract][Full Text] [Related]
19. Effect of firocoxib or flunixin meglumine on recovery of ischemic-injured equine jejunum.
Cook VL; Meyer CT; Campbell NB; Blikslager AT
Am J Vet Res; 2009 Aug; 70(8):992-1000. PubMed ID: 19645580
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of pimobendan following oral administration to New Zealand White rabbits (Oryctolagus cuniculus).
Ozawa SM; Guzman DS; Hawkins MG; Diao SM; Masri AE; Gunther-Harrington CT; Knych HK
Am J Vet Res; 2022 Jan; 83(4):356-363. PubMed ID: 35038306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]